Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-259842
Filing Date
2023-10-20
Accepted
2023-10-20 14:31:05
Documents
8
Period of Report
2023-10-20

Document Format Files

Seq Description Document Type Size
1 6-K d568063d6k.htm 6-K 8956
2 EX-99.1 d568063dex991.htm EX-99.1 25307
3 EX-99.2 d568063dex992.htm EX-99.2 29600
4 EX-99.3 d568063dex993.htm EX-99.3 18283
5 GRAPHIC g568063g20m29.jpg GRAPHIC 77246
6 GRAPHIC g568063g44r63.jpg GRAPHIC 5493
7 GRAPHIC g568063g86v74.jpg GRAPHIC 1838
8 GRAPHIC g568063g94j67.jpg GRAPHIC 24999
  Complete submission text file 0001193125-23-259842.txt   234806
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 231336904
SIC: 2834 Pharmaceutical Preparations